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1. Introduction 
Ferritin-conjugated proteins, such as lectins and 
antibodies, are widely used for localization of cell 
surface receptors in the electron microscope [ 1,2] . 
Procedures designed to effect direct covalent coupling 
of ferritin to the binding-protein are, for the most 
part, cumbersome and inefficient. The resultant 
complex is of high molecular weight - often a multi- 
mer - thus affecting both the physical and chemical 
binding characteristics and the biological activity of 
the conjugate. 
Biotin, derivatized to bacteriophages via the 
terminal carboxy moiety, has previously been shown 
to be available for subsequence interaction with 
avidin, resulting in phage inactivation [3] . A later 
investigation demonstrated that ferritin-avidin 
conjugates can be used for the specific labeling of 
biotin-tagged proteins and membrane preparations 
[4]. Recently, we have described an improved techni- 
que for the preparation of ferritin-avidin conjugates 
for use as an ultrastructural marker in the localization 
of surface receptor sites on biotin-derivatized whole 
cells [S] . The visualization of tRNA hybridized to 
DNA has also been reported [6]. 
**Abbreviations: Con A, concanavalin A; PNA, peanut 
agglutinin; rAb, goat gamma globulin against rabbit red 
blood cell membranes; mAs, antiserum against mouse 
erythrocyte membranes; B-Con A, B-PNA B-rAb, B-mAs 
- biotinylated-Con A, etc.; FAv, ferritin-avidin conju- 
gates; rRBC, mRBC, hRBC - rabbit, mouse and human 
erythrocytes, respectively; BNHS, biotinyl-Whyd.roxy- 
succinimide ester; PBS, phosphate buffered saline, pH 7.2; 
VELS, Verona&acetate buffered saline, pH 7.4. 
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In the present communication, we describe the 
further use of ferritin-avidin conjugates for the 
visualization of Con A**, PNA and antibody receptor 
sites on erythrocytes. The study is based on the 
interaction between ferritin-avidin and biotinylated 
binding proteins and is comprised of the following 
steps: (a) Biotin is covalently attached to the desired 
binding protein. (b) The characterized conjugate is 
incubated with appropriate cells. (c) Subsequent 
incubation with FAv enables the visualization of the 
given cell surface receptor. It is hoped that this 
approach may unify affinity cytochemical techniques 
and circumvent some of the problems related to 
ferritin-protein conjugation. 
2. Materials and methods 
2.1. Chemicals and synthesis 
BNHS was prepared from biotin and N-hydroxy- 
succinimide (both purchased from Sigma Chem. Corp.) 
in the presence of dicyclohexylcarbodiimide (Fluka) 
as described previously [3,7]. Other reagents were of 
the highest commercial grade available. 
2.2. Proteins 
The preparation of ferritin-avidin conjugates 
(FAv) was described previously [S] . Concanavalin A 
(Con A) was purchased from Miles Yeda Ltd. Peanut 
agglutinin (PNA) was kindly provided by N. Sharon 
[8]. Rabbit antimouse RBC antiserum and goat 
antirabbit RBC antiserum were prepared as previously 
described [9]. Goat Ig was separated by ammonium 
sulfate fractionation. 
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2.3. Preparation of biotin derivatized proteins 
Con A was treated with various molar ratios of 
BNHS in a solution of 0.1 M sodium bicarbonate 
containing 1 M sodium chloride (see table 1). The 
reaction was allowed to proceed for 4 h at room 
temperature, and the biotinylated samples were 
dialyzed overnight against PBS with several buffer 
changes. 
The amount of biotin per conjugate was deter- 
mined by deamination and subsequent amino acid 
analysis of biotin-protected lysines [lo] . Quantifica- 
tion of the extent of exposed biotin moieties/conju- 
gates was accomplished by retention on avidin- 
Sepharose columns [ 111. Affinity chromatography 
on avidin columns was performed in the presence 
of 0.2 M glucose. The effect of the attached biotinyl 
residues on the activity of Con A was analyzed by 
an agglutination assay of rabbit erythrocytes using a 
Fragiligraph [ 121. 
2.4. Procedure for labeling cell surface receptors 
Rabbit, mouse or human erythrocytes were iso- 
lated from fresh heparinized blood by sedimentation, 
rinsed twice in VBS and fixed briefly for 2 min at 
room temperature with 2% glutaraldehyde in VBS. 
Aliquots of lo7 cells were washed three times in VBS 
and then incubated for 30 min at room temperature 
with an appropriate solution of B-lectins or B-rAb at 
a concentration of 1 mg protein/ml, or in 5% B-mAs. 
Neuraminidase treatment preceding B-PNA incubation 
was carried out as previously described [8]. Controls 
were performed in the presence of 0.2 M of the 
competitive sugar or with underivatized lectins and 
antibodies. After the previous step, cells were washed 
three times with VBS and treated with FAv (1 mg/ml 
in ferritin) for 15 min at room temperature. Next, 
cells were rinsed twice with VBS and additionally 
fixed with 2% glutaraldehyde for 30 min. Processing 
for electron microscopy was carried out as previously 
reported [S] . 
3. Results and discussion 
3.1. Characterization of derivatized Con A 
The successful application of this method requires 
that the biotinylated protein be subject to unhindered 
interaction both with its receptor as well as the 
ferritin-avidin conjugate. In other words, the amount 
of biotin derivatized to the protein should be sufficient 
to react with avidm and, at the same time, should 
not be too much so as to disturb the binding of the 
protein to its receptor. The example of biotin-conju- 
gated Con A will demonstrate this principle. 
The derivatization of biotin, by means of its 
N-hydroxysuccinimide ester, to Con A was nearly 
quantitative as determined by amino acid analysis 
(table 1). In order to check the avidin-binding 
capacity of these conjugates, samples were adsorbed 
to a column of avidin-Sepharose. In a conjugate 
containing an average of about 5 biotin residues per 
tetramer, 60% was retained on avidinSepharose. An 
average of 15 biotin molecules/tetramer esulted in 
80% binding to such columns. Full binding could not 
be achieved until attachment of 30 biotins/tetramer. 
It is apparent that nearly total derivatization is 
necessary in order to ensure complete interaction 
between the biotinylated protein and avidinSepharose. 
This phenomenon is surprising, considering the extra- 
ordinary affinity between biotin and avidin [ 131. 
Accordingly, a portion of the derivatized biotin 
residues are apparently unexposed and not available 
for combination with avidin-Sepharose. It should be 
noted, however, that this does not exclude the 
Table 1 
Analysis of biotin-derivatized Con A saniples 
B-Con A 
Sample 
Amount (mg) 
Con A BNHS 
Biotin/dimer 
Molar ratio 
Retained on 
avidin column 
(%I 
Protected 
lysines 
(per dimer) 
A 
B 
C 
D 
100 2.8 4.4 59 
100 5.6 8.8 79 
100 11.2 17.6 92 
10 5.0 77.8 n.d. 
2-3 
7-9 
n.d. 
total 
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TIME (min) 
Fig.1. Rate of rRBC agglutination by native (N) and biotinyl-Con A preparations (Samples A-D, table 1). L.T.: Light transmission. 
possibility of complete interaction between FAv and 
B-proteins in solution. Binding of the latter to mem- 
brane receptors may cause conformational changes, 
resulting in the exposure of more biotinyl residues for 
complex formation with avidin. 
In order to determine the effect of biotinylation on 
biological activity, an agglutination assay using 
rRBC was performed. As can be seen from fig. 1, most 
of the derivatives were still capable of agglutinating 
the cells. However, supersaturation of Con A with 
biotin (sample D) had several undesirable attributes. 
First, rRBC agglutination was completely inhibited 
(fig.1) indicating that the biological activity of this 
sample was significantly altered - but not destroyed, 
since total retention by affinity chromatography on 
Sephadex G-75 was observed. The combined lack of 
rRBC agglutination versus binding to Sephadex, 
implies that this sample may have been converted to 
a monovalent form of Con A by heavy biotinylation - 
similar to that obtained by chemical [ 141 or by 
enzymatic means [ 15,161. The final inadequacy of 
this sample was observed under the electron micros- 
cope in the form of extensive aggregates. 
In view of these results, it is therefore advisable to 
derivatize proteins under near-saturating conditions, 
but to avoid excessive treatment with BNHS. A sample, 
at least 80% of which binds to avidinSepharose, is 
probably appropriate for the studies described in this 
report. Similar results were also obtained with biotinyl- 
ated PNA and antibodies. 
3.2. Specific labeling of the cell surface 
rRBC, incubated with B-PNA, B-Con A or B-rAb 
were specifically labeled with FAv (figs.2 and 3). When 
Fig.2. rRBC treated with B-Con A and labeled with FAv. 
Fig.3. rRBC incubated with B-rAb and labeled with FAv. 
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Fig.4. rRBC treated with B-Con A in 0.1 M glucose and labeled with FAv. 
Fig.5 hRBC treated with B-PNA and FAv. 
Fig.6. hRBC treated with 50 U/ml neuraminidase, incubated with B-PNA and labeled with FAv. 
the cells were incubated with B-Con A or B-PNA in 
the presence of their competitive sugar, no labeling 
was observed (fig.4). hRBC also lacked labeling when 
incubated with B-PNA followed by FAv, since mem- 
brane receptors for this lectin are not exposed (fig.5). 
However, treatment of these cells with neuraminidase 
removes sialic acid residues and exposes the Gal-& 
(1+3)GalNAc sequence [8]. These cells were highly 
labeled by sequential treatment with B-PNA and FAv 
(fig.6). Localization of cell receptors is not confined 
to purified protein preparations, since specific labeling 
was also obtained by biotin-derivatized unfractionated 
antiserum. Thus mRBC (but neither rRBC nor hRBC) 
were labeled with FAv upon prior incubation with 
B-mAs. 
An interesting observation involved the presence 
of FAv labeling of rRBC after incubation with 
underivatized Con A. Since avidin is a mannose- 
bearing glycoprotein, the free binding sites of the 
membrane-bound, multi-subunit lectin are available 
for further interaction with FAv. This explanation is 
supported by the fact that neither underivatized PNA, 
Ab or As affected FAv labeling of the cell surface. 
Indeed, such ‘nonspecific’ Con A-induced labeling 
could be prevented by prior fmation of Con A treated 
cells with glutaraldehyde, followed by incubation 
with FAv in a glucose-containing medium. Under these 
conditions, the label was more evenly distributed. 
The distribution of FAv on cells treated with 
biotinylated proteins was similar in every case to that 
of the respective protein-ferritin conjugate. These 
results indicate that chemical binding of biotin to 
lectins and antibodies does not interfere with their 
specificity and binding capacity to cell surface 
receptors and antigenic determinants. 
In summation, the above-outlined procedure is 
appealing for a variety of reasons: (a) Only one 
ferritin-protein conjugate (FAv) need be prepared 
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and characterized for all affinity systems; (b) Biotin 
can be attached to small ligands and macromolecules 
efficiently and under very mild conditions; (c) The 
size, physical characteristics, and biological activity 
of the biotin-derivatized proteins examined, are only 
nominally affected; (d) The biotin-avidin complex 
is of exceptionally high affinity and stability; and 
(e) Avidin and biotin are both commercially available 
in large quantities. 
Since fixation does not interfere with FAv labeling, 
cells may be fixed at various time intervals after inter- 
action with biotinylated proteins. Subsequent treat- 
ment with FAv or fluorescent-labeled avidin may 
enable kinetics studies of the interaction between 
such proteins and cell membranes. This topic is 
currently under investigation. 
Acknowledgements 
This work was supported in part by a grant from 
the Israel Commission for Basic Research. 
References 
111 
121 
[31 
I41 
[51 
[61 
171 
181 
1191 
1101 
1111 
1121 
1131 
1141 
1151 
[I61 
Singer, S. J. and Schick, A. F. (1961) J. Biophys. 
Biochem. Cytol. 9, 519-537. 
Nicolson, G. L. and Singer, S. J. (1971) Proc. Natl. Acad. 
Sci. USA 68,942-945. 
Becker, J. M. and Wilchek, M. (1972) Biochim. Biophys. 
Acta 264, 165-170. 
Heitzmann, H. and Richards, F. M. (1974) Proc. Natl. 
Acad. Sci. USA 71, 3537-3541. 
Bayer, E., Skutelsky, E., Wynne, D. and Wilchek, M. 
(1976) J. Histochem. Cytochem. 24 (6), in press. 
Manning, J. E., Hershey, N. D., Broker, T. R., 
Pellegrini, M., Mitchell, H. K. and Davidson, N. (1975) 
Chromasoma (Berl.) 53, 107-l 17. 
Bayer, E. and Wiichek, M. (1974) Meth. Enzymol. 34, 
265-267. 
Lotan, R., Skutelsky, E., Danon, D. and Sharon, S. 
(1975) J. Biol. Chem. 250, 8518-8523. 
Skutelsky, E., Marikovsky, Y. and Danon, D. (1974) 
Eur. J. Immunol. 4, 5 12-5 18. 
Anfinsen, C. B., Sela, M. and Cook, J. D. (1962) J. Biol. 
Chem. 237,1825-1831. 
Bodansky and Bodansky (1970) Experientia 26, 327. 
Danon, D., Marikovsky, Y. and Kohn, A. (1969) 
Experientia 25, 104-106. 
Green, N. M. (1975) Adv. Prot. Chem. 29,55-130. 
Fraser, A. R., Hemperly, J. J., Wang, J. L. and Edelman, 
G. M. (1976) Proc. Natl. Acad. Sci. USA 73, 790-794. 
Thomasson, D. L. and Doyle, R. J. (1975) Biochem. 
Biophys. Res. Commun. 67, 1545-1552. 
Wands, J. R., Podolsky, D. K. and Isselbacher, K. J. 
(1976) Proc. Natl. Acad. Sci. 73, 2118-2122. 
244 
